Wolfram syndrome 1 gene regulates pathways maintaining beta-cell health and survival.
| Citation | Abreu, Damien, et al. “Wolfram Syndrome 1 Gene Regulates Pathways Maintaining Beta-Cell Health and Survival”. 2020. Laboratory Investigation; A Journal of Technical Methods and Pathology, 2020. |
| Center | Washington University in St Louis |
| Author | Damien Abreu, Rie Asada, John M P Revilla, Zeno Lavagnino, Kelly Kries, David W Piston, Fumihiko Urano |
| Abstract |
Wolfram Syndrome 1 (WFS1) protein is an endoplasmic reticulum (ER) factor whose deficiency results in juvenile-onset diabetes secondary to cellular dysfunction and apoptosis. The mechanisms guiding β-cell outcomes secondary to WFS1 function, however, remain unclear. Here, we show that WFS1 preserves normal β-cell physiology by promoting insulin biosynthesis and negatively regulating ER stress. Depletion of Wfs1 in vivo and in vitro causes functional defects in glucose-stimulated insulin secretion and insulin content, triggering Chop-mediated apoptotic pathways. Genetic proof of concept studies coupled with RNA-seq reveal that increasing WFS1 confers a functional and a survival advantage to β-cells under ER stress by increasing insulin gene expression and downregulating the Chop-Trib3 axis, thereby activating Akt pathways. Remarkably, WFS1 and INS levels are reduced in type-2 diabetic (T2DM) islets, suggesting that WFS1 may contribute to T2DM β-cell pathology. Taken together, this work reveals essential pathways regulated by WFS1 to control β-cell survival and function primarily through preservation of ER homeostasis. |
| Year of Publication |
2020
|
| Journal |
Laboratory investigation; a journal of technical methods and pathology
|
| Date Published |
02/2020
|
| ISSN Number |
1530-0307
|
| DOI |
10.1038/s41374-020-0408-5
|
| Alternate Journal |
Lab. Invest.
|
| PMID |
32060407
|
| Download citation |